Anemia in the Elderly: Introduction

Seminars in Hematology

Volumn 45, Issue 4, 2008, Pages 207-209

  Price, Elizabeth A ^a   Schrier, Stanley L ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; CYSTATIN C; ERYTHROPOIESIS STIMULATING AGENT; FERRITIN; HEMOGLOBIN; IRON; PLASMA SUBSTITUTE; TRANSFERRIN; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; AGED; ANEMIA; CANCER HORMONE THERAPY; CAUCASIAN; CHRONIC DISEASE; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; DRUG SAFETY; EDITORIAL; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; FRAIL ELDERLY; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; IDIOPATHIC DISEASE; INFLAMMATION; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; IRON THERAPY; KIDNEY DISEASE; KIDNEY FAILURE; MEAN CORPUSCULAR VOLUME; MORBIDITY; MORTALITY; MYELODYSPLASTIC SYNDROME; NUTRITIONAL DEFICIENCY; PATIENT MONITORING; PLASMA VOLUME; POLYCYTHEMIA; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; TESTOSTERONE BLOOD LEVEL; THALASSEMIA; THROMBOEMBOLISM; TRANSFERRIN BLOOD LEVEL;

AGED; AGING; ANEMIA; FEMALE; HEMOGLOBINS; HUMANS; MALE; PREVALENCE;

EID: 52049115174     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2008.07.001     Document Type: Editorial

References (30)

1. Beghe C., Wilson A., and Ershler W.B. Prevalence and outcomes of anemia in geriatrics: A systematic review of the literature. Am J Med 116 suppl 7A (2004) 3S-10S
2. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 405 (1968) 5-37
3. Beutler E., and Waalen J. The definition of anemia: What is the lower limit of normal of the blood hemoglobin concentration?. Blood 107 (2006) 1747-1750
4. Guralnik J.M., Eisenstaedt R.S., Ferrucci L., Klein H.G., and Woodman R.C. Prevalence of anemia in persons 65 years and older in the United States: Evidence for a high rate of unexplained anemia. Blood 104 (2004) 2263-2268
5. Patel K.V., Harris T.B., Faulhaber M., Angleman S.B., Connelly S., Bauer D.C., et al. Racial variation in the relationship of anemia with mortality and mobility disability among older adults. Blood 109 (2007) 4663-4670
6. Penninx B.W., Pluijm S.M., Lips P., Woodman R., Miedema K., Guralnik J.M., et al. Late-life anemia is associated with increased risk of recurrent falls. J Am Geriatr Soc 53 (2005) 2106-2111
7. Penninx B.W., Pahor M., Woodman R.C., and Guralnik J.M. Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci 61 (2006) 474-479
8. Penninx B.W., Guralnik J.M., Onder G., Ferrucci L., Wallace R.B., and Pahor M. Anemia and decline in physical performance among older persons. Am J Med 115 (2003) 104-110
9. Denny S.D., Kuchibhatla M.N., and Cohen H.J. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med 119 (2006) 327-334
10. Chaves P.H., Carlson M.C., Ferrucci L., Guralnik J.M., Semba R., and Fried L.P. Association between mild anemia and executive function impairment in community-dwelling older women: The Women's Health and Aging Study II. J Am Geriatr Soc 54 (2006) 1429-1435
11. Zakai N.A., Katz R., Hirsch C., Shlipak M.G., Chaves P.H., Newman A.B., et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: The Cardiovascular Health Study. Arch Intern Med 165 (2005) 2214-2220
12. Chaves P.H., Xue Q.L., Guralnik J.M., Ferrucci L., Volpato S., and Fried L.P. What constitutes normal hemoglobin concentration in community-dwelling disabled older women?. J Am Geriatr Soc 52 (2004) 1811-1816
13. Culleton B.F., Manns B.J., Zhang J., Tonelli M., Klarenbach S., and Hemmelgarn B.R. Impact of anemia on hospitalization and mortality in older adults. Blood 107 (2006) 3841-3846
14. Bohlius J., Wilson J., Seidenfeld J., Piper M., Schwarzer G., Sandercock J., et al. Recombinant human erythropoietins and cancer patients: Updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst 98 (2006) 708-714
15. Joosten E., Ghesquiere B., Linthoudt H., Krekelberghs F., Dejaeger E., Boonen S., et al. Upper and lower gastrointestinal evaluation of elderly inpatients who are iron deficient. Am J Med 107 (1999) 24-29
16. Gordon S.R., Smith R.E., and Power G.C. The role of endoscopy in the evaluation of iron deficiency anemia in patients over the age of 50. Am J Gastroenterol 89 (1994) 1963-1967
17. Carmel R., Green R., Rosenblatt D.S., and Watkins D. Update on cobalamin, folate, and homocysteine. Hematology (Am Soc Hematol Educ Program) (2003) 62-81
18. Rimon E., Levy S., Sapir A., Gelzer G., Peled R., Ergas D., et al. Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch Intern Med 162 (2002) 445-449
19. Punnonen K., Irjala K., and Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 89 (1997) 1052-1057
20. Pfeiffer C.M., Cook J.D., Mei Z., Cogswell M.E., Looker A.C., and Lacher D.A. Evaluation of an automated soluble transferrin receptor (sTfR) assay on the Roche Hitachi analyzer and its comparison to two ELISA assays. Clin Chim Acta 382 (2007) 112-116
21. Worwood M. Serum transferrin receptor assays and their application. Ann Clin Biochem 39 (2002) 221-230
22. Stevens L.A., Coresh J., Schmid C.H., Feldman H.I., Froissart M., Kusek J., et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 51 (2008) 395-406
23. Strum S.B., McDermed J.E., Scholz M.C., Johnson H., and Tisman G. Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade. Br J Urol 79 (1997) 933-941
24. Physician's Package Insert, AndroGel, Unimed Pharmaceuticals, Rev 4/2004
25. Zurlo M.G., De Stefano P., Borgna-Pignatti C., Di Palma A., Piga A., Melevendi C., et al. Survival and causes of death in thalassaemia major. Lancet 2 (1989) 27-30
26. Olivieri N.F., Brittenham G.M., McLaren C.E., Templeton D.M., Cameron R.G., McClelland R.A., et al. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med 339 (1998) 417-423
27. Harmatz P., Butensky E., Quirolo K., Williams R., Ferrell L., Moyer T., et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood 96 (2000) 76-79
28. Wood J.C., Tyszka J.M., Carson S., Nelson M.D., and Coates T.D. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 103 (2004) 1934-1936
29. Konen E., Ghoti H., Goitein O., Winder A., Kushnir T., Eshet Y., et al. No evidence for myocardial iron overload in multitransfused patients with myelodysplastic syndrome using cardiac magnetic resonance T2 technique. Am J Hematol 82 (2007) 1013-1016
30. Rose C., Brechignac S., Vassilief D., Beyne-Rauzy O., Stamatoullas A., Larbaa D., et al. Positive impact of iron chelation therapy (CT) on survival in regularly transfused MDS patients. A prospective analysis (2007) Presented at the American Society of Hematology Annual Meeting, Atlanta, GA